Higher GLP-1 Dosing and Weight Loss, Extended CGM Wear and New FDA Approvals, Hot Take on the Optimal Blood Glucose Targets | TCOYD® Newsy News #5
In this video, you will learn about the following:
✔ New data from the makers of Ozempic and Wegovy, Novo Nordisk, shows a dramatic reduction in weight with increased weekly dose of insulin
✔ Updates from Dexcom with a new extended sensor life from 10 to 15 days
✔ Newly approved by FDA CGM from Medtronic called Simplera that could simplify daily diabetes management routines
✔The ongoing professional discussion regarding optimal blood glucose targets and their real-world implications (time in tight range vs. time in range)
✔Is diabetes “know-it-allism” a thing? How to handle diabetes advice from non-experts who know it better?
CHECK OUT OUR LATEST EPISODES OF DIABETES NEWSY NEWS
FDA Denies T1D SGLT Drug, Dexcom/Oura Ring, Abbott's Ketone Monitor, Medtronic KLUE
TCOYD® Newsy News #4
New Data on Ozempic, Mounjaro, the iLet Bionic Pancreas and more!
TCOYD® Newsy News #3
Mounjaro Weight Loss Data, Medicare CGM Coverage, $35 Insulin News
TCOYD® Newsy News #2
Mounjaro Weight Loss Data, Medicare CGM Coverage, $35 Insulin News
TCOYD® Newsy News #1
Newsy News is a video series for healthcare professionals & advanced learners living with diabetes to stay up to date on what’s happening in the diabetes world. Inspired by SNL’s Weekend Update, this new video news segment covers the latest updates and exciting advancements in diabetes care and explains how the research translates to real life.
OUR MISSION
Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, TCOYD® educates & motivates people with diabetes to take a more active role in their condition and provides innovative & integrative continuing education to medical professionals caring for people with diabetes.
OUR VISION
For all people with diabetes and their loved ones to have full access to proper education and therapy to aid in the prevention, early detection and aggressive management of diabetes and its complications.
Cure breakthroughs
Libre cgm. Has 3 been recalled .? Why are they adding a 2 and and a 4
In the fall ? What do I do until then ?
I’m not sure when any new versions will be coming out – just keep using yours. When they have new models, they don’t immediately discontinue the old ones.
Having a really tight time in range was not a good route for me. I am a non-insulin resistant type 2 diabetic that uses mealtime insulin. have had countless lows trying to curve the meal spike to under 140 (too much insulin needed) so i stopped using Lispro and went with a very restrictive diet which worked but at a metabolic price. i ended up losing 25 lbs in a short 2 months which i did not need to (normal BMI). Fast forward i am now using Fiasp for meals, am able to eat better and have dial in the boluses to keep the spikes under 180 and no LOWS!. i also gained back 10 lbs and have better energy levels. Just my experience here.